Source: WIPO — World Intellectual Property Indicators 2024

Why this matters: India’s headline patent growth masks low per-capita innovation intensity, revealing shallow domestic R&D diffusion.

The Private Sector Problem: Why Indian Firms Don’t Bet on Deep Tech

Indian industry’s reluctance to invest in deep, long-horizon R&D is not simply cultural; it is structural. Most large Indian firms operate in sectors where returns are driven by scale, regulation, or cost efficiency, not by technological frontier-pushing. Unlike firms in the U.S. or China, Indian corporations face limited domestic demand for frontier products such as advanced semiconductors, biotech platforms, or high-end industrial materials.

Another critical factor is the absence of innovation-anchoring government procurement. In the U.S. and China, defence, healthcare, energy, and infrastructure procurement act as guaranteed early markets for risky technologies, allowing firms to amortise R&D costs. India’s public procurement system, by contrast, remains price-centric and risk-averse, rarely functioning as a demand-side catalyst for innovation.

Capital structure matters too. Indian corporate finance remains biased toward short payback periods and predictable cash flows, discouraging investments whose returns may materialise only after a decade. Even when balance sheets are strong, firms prefer acquisitions, capacity expansion, or foreign technology licensing over uncertain in-house research. The result is a private sector that is commercially successful but technologically shallow, unable to anchor a national innovation ecosystem.

Source: UNESCO, OECD STI Outlook

Why this matters: In innovation-led economies, industry drives R&D. In India, the state still carries the burden — limiting scale, speed, and risk-taking.

The Innovation Leakage: Education → Research → Value Capture

India’s innovation pipeline leaks at every stage. The country produces a large number of STEM graduates and PhDs, but a significant share of its most productive researchers work abroad, particularly in the U.S. and Europe. India consistently ranks among the top contributors to global scientific manpower, yet captures only a small fraction of the resulting intellectual property rents.

Patent data illustrates the problem starkly. While India’s total patent filings have grown rapidly, its share of high-value patent families — those filed in multiple major jurisdictions — remains low. Even fewer patents translate into licensed technologies, spin-offs, or exportable products. By contrast, countries like South Korea and Israel exhibit far higher patent-to-commercialisation ratios, despite smaller populations.

At the macro level, this leakage shows up in trade data. India is a global leader in services exports, but remains a marginal player in IP-intensive goods exports. In effect, India supplies talent and code but imports chips, equipment, and proprietary platforms — paying long-term IP rents to foreign firms while under-monetising its own human capital.

The Missed Middle: Why India Has Startups but Not Scale-Up Science

India’s startup ecosystem is vibrant, but skewed. Venture capital overwhelmingly favours consumer technology, fintech, SaaS, and platform models — sectors where speed to market matters more than scientific depth. Capital-intensive domains such as semiconductors, advanced materials, life sciences, and clean-energy hardware attract only a fraction of total VC funding.

The missing link is the “scale-up science” stage: moving from lab-validated technology to industrial-scale production. In advanced economies, this stage is often supported by national labs, defence agencies, or public-private consortia. In India, public research labs are weakly integrated with startups, and regulatory uncertainty further raises risk in sectors like biotech and energy storage.

As a result, India generates unicorns but very few globally competitive deep-tech firms. Startup valuations grow faster than scientific capability, reinforcing an ecosystem that excels at market innovation but struggles with technological sovereignty.

Global Benchmarks That Actually Matter (Beyond Spend Ratios)

Comparing R&D as a percentage of GDP tells only part of the story. More revealing metrics show how far India lags in innovation intensity and efficiency. India has far fewer researchers per million population than China, South Korea, or OECD averages. Its R&D spend per researcher is also significantly lower, limiting the complexity and ambition of projects researchers can undertake.

Output efficiency is another gap. India produces fewer patent families per billion dollars of R&D than advanced innovation economies. Government procurement as a share of innovation demand — a key lever in the U.S. and China — remains underutilised in India. These indicators collectively show that India’s challenge is not only scale, but system design.

Source: WIPO Global Innovation Index

Why this matters: India’s improving rank reflects ecosystem breadth, not research depth — a key distinction often missed in public debate.